Your session is about to expire
← Back to Search
AT-007 for Galactosemia
Study Summary
This trial will study if AT-007 is safe and helpful for kids with Classic Galactosemia, a disorder where the body can't metabolize galactose.
- Classic Galactosemia
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many people are signing up to participate in this experiment?
"This specific clinical trial is no longer recruiting patients. The study was posted on 3/20/2021 and the most recent update was 2/16/2022. Currently, there are 4 other trials related to classic galactosemia enrolling patients and 1 for AT-007."
Which type of people would be best suited for this research project?
"This study is in need of 47 test subjects that have classic galactosemia and are aged 2-17. The following additional criteria must be met: Male, Female non-pregnant, Female non-lactating subjects aged ≥2 to <18 years., Male/Female with no significant health problems (other than classic Galactosemia), No other disease that would preclude participation in the study."
Has this research been conducted before?
"Research on AT-007 started in 2021 with a clinical trial sponsored by Applied Therapeutics, Inc. The study had 47 participants and after its successful completion, AT-007 moved onto Phase 2 & 3 of drug approval. Currently, there is one active trial for AT-007 being conducted by Applied Therapeutics, Inc.."
Are there any open appointment times for this test?
"This trial is no longer recruiting patients. The study was first posted on March 20th, 2021 and had its last update on February 16th, 2022. Currently, there are 4 clinical trials for classic galactosemia and 1 trial for AT-007 that are actively admitting patients."
Does this research project have an age limit for participants?
"According to the age bracket that is eligible for this clinical trial, the minimum age requirement for enrollment is 2 years old while the maximum age limit is 17."
What other medical research has been conducted using AT-007?
"Right now, there is 1 large-scale study and 1 smaller trial studying AT-007. Phase 3 trials are ongoing in Ann Arbor, Michigan as well as 2 other locations."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger